Skip to main content
. 2006 Apr 4;94(8):1107–1115. doi: 10.1038/sj.bjc.6603058

Table 6. Serum CA19-9 in trial A.

  Gastrazole (kU l−1) Number of patients with measurement Placebo (kU l−1) Number of patient with measurement
Baseline median level 312 8 403 9
         
Change from baseline median
 At 6 weeks 21 8 913 9
 At 12 weeks 594 9 3234 9
 At 18 weeks 739 8 50 533 4